Cross-Sector Partnerships: How Big Deals Move Markets in 2026
Deal contagion spreads across asset classes: a pharma-tech partnership can simultaneously reprice biotech equities, semiconductor stocks, and even risk-on crypto assets. The 72-hour window after a partnership announcement is historically the highest-velocity period, late entrants often chase momentum already captured by pre-positioned traders. Leverage amplifies both the opportunity and the liquidation risk: understanding announcement volatility, spread widening, and funding costs is essential before sizing any partnership-event trade.